Adel Chergui
Impact in
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
-
- Synthesis and Biological Evaluation
- Synthesis and biological activity
Papers in
-
- Cancer therapeutics and mechanisms 7
- Oncology 7
- Colorectal Cancer Treatments and Studies 3
- Colorectal Cancer Screening and Detection 2
- Co-authors
- Yves Pommier (8 shared papers)Christophe Marchand (7 shared papers)Mark Cushman (3 shared papers)Keli Agama (3 shared papers)Andrew G. Stephen (4 shared papers)Martin Conda‐Sheridan (2 shared papers)Andrew Morrell (2 shared papers)Amèlie Renaud (2 shared papers)
- Journals
- Journal of Medicinal Chemistry (5 papers)Journal of Clinical Oncology (3 papers)Molecular Cancer Therapeutics (1 paper)SLAS DISCOVERY (1 paper)Cancers (1 paper)
- Partner nations
- United StatesJapan
In The Last Decade
Adel Chergui
16 papers receiving 381 citations
Peers
Comparison fields: 5 of 52
- Toxicology 69
- Organic Chemistry 151
- Molecular Biology 280
- Oncology 98
- Pharmacology 50
Countries citing papers authored by Adel Chergui
This map shows the geographic impact of Adel Chergui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adel Chergui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adel Chergui more than expected).
Fields of papers citing papers by Adel Chergui
This network shows the impact of papers produced by Adel Chergui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adel Chergui. The network helps show where Adel Chergui may publish in the future.
Co-authors
The 25 scholars most cited alongside Adel Chergui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 82 | |
| 2 | 2012 | 67 | |
| 3 | 2014 | 60 | |
| 4 | 2012 | 56 | |
| 5 | 2014 | 49 | |
| 6 | 2017 | 19 | |
| 7 | 2014 | 19 | |
| 8 | 2014 | 17 | |
| 9 | 2023 | 11 | |
| 10 | [Non invasive measurement of the cerebral blood flow in infants with hydrocephalus]. | 1985 | 5 |
| 11 | 2019 | 2 | |
| 12 | 2021 | 1 | |
| 13 | 2020 | 1 | |
| 14 | 2022 | 1 | |
| 15 | [Ultrasonic diagnosis and follow-up of aneurysms of the ampulla of Galen in infants]. | 1987 | 1 |
| 16 | [Echographic monitoring of post-hemorrhagic ventricular dilatations in premature newborn infants. Value of the determination of a ventricular index]. | 1985 | 1 |
About Adel Chergui
Adel Chergui is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Neurology and Toxicology, having authored 16 papers that have together received 392 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (7 papers), Bioactive Compounds and Antitumor Agents (3 papers), Traumatic Brain Injury and Neurovascular Disturbances (3 papers), Synthesis and biological activity (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Synthesis and Biological Activity (2 papers), Neonatal and fetal brain pathology (2 papers) and Colorectal Cancer Screening and Detection (2 papers). The work is most often cited by research in Toxicology (69 citations), Organic Chemistry (151 citations), Molecular Biology (280 citations), Oncology (98 citations) and Pharmacology (50 citations). Adel Chergui has collaborated with scholars based in United States and Japan. Frequent co-authors include Yves Pommier, Christophe Marchand, Mark Cushman, Keli Agama, Andrew G. Stephen, Martin Conda‐Sheridan, Andrew Morrell, Amèlie Renaud, Barry R. O’Keefe and Junko Murai. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Clinical Oncology, Molecular Cancer Therapeutics, SLAS DISCOVERY and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.